Guillain Barrè syndrome and myelitis associated with SARS-CoV-2 infection.
Neurosci Lett
; 759: 136040, 2021 08 10.
Article
en En
| MEDLINE
| ID: mdl-34118307
ABSTRACT
Despite a likely underestimation due to the many obstacles of the highly infectious, intensive care setting, increasing clinical reports about COVID-19 patients developing acute paralysis for polyradiculoneuritis or myelitis determine additional impact on the disease course and outcome. Different pathogenic mechanisms have been postulated basing on clinical, laboratory and neuroimaging features, and response to treatments. Here we provide an overview with insights built on the available reports. Besides direct viral pathogenicity, a crucial role seems to be represented by immune-mediated mechanisms, supporting and further characterizing the already hypothesized neurotropic potential of SARS-CoV-2 and implying specific treatments. Proper clinical and instrumental depiction of symptomatic cases, as well as screening for their early recognition is advocated.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Síndrome de Guillain-Barré
/
COVID-19
/
Mielitis
Tipo de estudio:
Risk_factors_studies
Idioma:
En
Revista:
Neurosci Lett
Año:
2021
Tipo del documento:
Article